ArticleBMC cancer2021

Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation.

Yukiko Kiniwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.